home / stock / apvo / apvo quote
Last: | $0.80 |
---|---|
Change Percent: | -1.73% |
Open: | $0.81 |
Close: | $0.80 |
High: | $0.82 |
Low: | $0.78 |
Volume: | 165,623 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.8 | $0.81 | $0.8 | $0.82 | $0.78 | 165,623 | 05-17-2024 |
$0.7962 | $0.8224 | $0.7962 | $0.8492 | $0.791 | 165,600 | 05-16-2024 |
$0.808 | $0.8099 | $0.808 | $0.8405 | $0.7901 | 129,254 | 05-15-2024 |
$0.828 | $0.849 | $0.828 | $0.87 | $0.8011 | 213,429 | 05-14-2024 |
$0.812 | $0.91 | $0.812 | $0.91 | $0.802 | 341,958 | 05-13-2024 |
$0.89 | $0.94 | $0.89 | $0.9649 | $0.88 | 188,546 | 05-10-2024 |
$0.935 | $1.04 | $0.935 | $1.04 | $0.915 | 346,989 | 05-09-2024 |
$1.025 | $1.12 | $1.025 | $1.15 | $1.01 | 344,069 | 05-08-2024 |
$1.16 | $1.12 | $1.16 | $1.19 | $1.03 | 585,539 | 05-07-2024 |
$1.11 | $1.01 | $1.11 | $1.14 | $1 | 819,073 | 05-06-2024 |
$0.989 | $1.02 | $0.989 | $1.09 | $0.9611 | 2,009,436 | 05-03-2024 |
$1.13 | $1.14 | $1.13 | $1.38 | $1.04 | 26,006,335 | 05-02-2024 |
$0.96 | $0.73 | $0.96 | $1.14 | $0.725 | 5,765,411 | 05-01-2024 |
$0.7107 | $0.72 | $0.7107 | $0.7493 | $0.7107 | 115,022 | 04-30-2024 |
$0.7499 | $0.76 | $0.7499 | $0.765 | $0.724 | 449,831 | 04-29-2024 |
$0.7061 | $0.6875 | $0.7061 | $0.72 | $0.68 | 172,519 | 04-26-2024 |
$0.68 | $0.68 | $0.68 | $0.707617 | $0.67 | 367,900 | 04-25-2024 |
$0.6826 | $0.749 | $0.6826 | $0.749 | $0.68 | 567,282 | 04-24-2024 |
$0.7362 | $0.7 | $0.7362 | $0.7646 | $0.7 | 348,472 | 04-23-2024 |
$0.71 | $0.711 | $0.71 | $0.72 | $0.67 | 169,421 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Aptevo Therapeutics Inc. Company Name:
APVO Stock Symbol:
NASDAQ Market:
Aptevo Therapeutics Inc. Website:
Lecture to focus on engineering strategies applied to design safe and efficacious bispecific drug candidates, utilizing our proprietary platform technologies SEATTLE, WA / ACCESSWIRE / May 14, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on ...
Heavily pre-treated breast cancer patient who achieved stable disease on study, remains on treatment for more than eleven months after entering the ALG.APV-527 Phase 1 trial with progressive disease and transitioning to higher dose with potential for greater clinical benefit, experienced no new a...
A look at the top 10 most actives in the United States Allarity Therapeutics Inc. (ALLR) rose 97.8% to $2.71 on volume of 44,141,232 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 1.1% to $0.0456 on volume of 28,670,184 shares Emergent Biosolutions Inc. (EBS) rose 67.7% to $3...